Indications

• Treatment and prevention of postmenopausal osteoporosis

• Treatment of osteoporosis in men

• Treatment of Paget's disease of the bone

• Treatment of corticosteroid-induced osteoporosis in patients (men and women) who are receiving >=7.5 mg of prednisone/day (or equivalent) with evidence of decreased bone mineral density

alendronate is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.